Searched for
SAUDI FDA APPROVAL
Venus Remedies gets Saudi FDA approval for speciality oncology therapyVenus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi ...- Can Rubicon Research sustain its impressive growth while facing US market risks?Rubicon Research plans to raise ₹500 crore through a fresh issue for debt repayment and acquisitions, alongside an ₹877.5 crore offer for s...
- Stocks in news: Sula Vineyards, Gujarat Gas, JSW Steel, ABFRL, NHPCSaudi Aramco has fixed September propane contract price at $550/tn as against current price of Rs $470/tn. In India, these prices will be a...
- Stocks in news: Hero MotoCorp, Lupin, Tata Power, RIL, Quess Corp, PNBThe Board of Hero MotoCorp appointed Niranjan Gupta as the new Chief Executive Officer (CEO) of the company, effective from May 1, 2023, el...
- Sensex gyrates 277 pts in choppy trade, ends 86 pts higher; Nifty tops 18,300The 30-share pack Sensex rose 85.88 points or 0.14 per cent to close at 61,308.91. The index gyrated in a range of 277 points. Its broader ...
- Glenmark gets marketing approval for Ryaltris in 13 EU, UK countriesSales of the nasal spray continue to progress well in Australia, South Africa, Ukraine and Uzbekistan, it said adding the company has also ...
- Bharat Biotech needs to give phase-3 efficacy data for WHO nodInclusion in the EUL is also important for easy international travel of Indian citizens who have been administered Covaxin.
- Explained: Where does the world stand in the race for a coronavirus vaccine?The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic, which has killed more than 1.8 milli...
- Explained: Where are we in the COVID-19 vaccine race?The European Union gave approval on Dec. 21 for the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, the latest regulatory go-ahea...
- Two vaccines hit snags as Pfizer nears US approvalFrance's Sanofi and Britain's GSK said on Friday their vaccine would not be ready until the end of 2021. New results showed a low immune re...
- US medical experts recommend emergency authorisation of Pfizer COVID vaccineAn emergency use authorisation (EUA) is short of a full approval. Pfizer would have to file a separate application for full FDA approval fo...
- US FDA grants emergency use authorization to Regeneron COVID-19 antibody given to TrumpThe FDA said the monoclonal antibodies, casirivimab and imdevimab, should be administered together for the treatment of mild to moderate CO...
- Russia's rush for Covid-19 inoculations could frustrate vaccine efforts elsewhereThe country’s plan to start mass inoculations as soon as October could put pressure on other governments to rush ahead of regulators and sk...
- Market Movers: What changed for D-Street while you were sleepingForeign portfolio investors (FPIs) bought Rs 1,130.78 crore worth of domestic stocks on Wednesday.
- Set to conquer US, Indian 'Viagras' may give Pfizer a hard timeThe nearing end of Pfizer's patent will open floodgates of the lucrative US market to Indian companies.
- Bloomberg's top 50 people who defined global business in 2017From finance and politics to tech and entertainment, these people defined global business in throughout the current year.
- PM Narendra Modi’s push for GM crops faces tough opposition from Swadeshi Jagaran ManchThe GM crops issue will test the Swadeshi Jagaran Manch’s will as well as the resolve of Narendra Modi's government.
- L&T plumps for global thrustIn a shift from its traditional strategy, Larsen and Toubro’s (L&T) electronics and electrical group (EBG) is looking at its international ...
Load More
